We are excited to share the publication of our latest research that explored the molecular effects of long-term pharmacological LRRK2 inhibition in vivo. This comprehensive study was completed by Ph.D. candidate Jillian H. Kluss in the lab of Dr. Mark R. Cookson at the National Institute on Aging, NIH.
By Todd Taylor New research provides insight into how inflammation, bacterial populations and levels of short-chain fatty acids, or SCFAs, might be linked to the development of Parkinson’s disease. The study, published in the journal Molecular Neurodegeneration, was co-authored by Malú Tansey, co-director of UF’s Center for Translational Research in…
January 2021 cover of the journal Movement Disorders Malú Tansey, Ph.D., was featured on the cover of the January 2021 journal of the International Parkinson and Movement Disorder Society for her work entitled “Genetic and environmental…
Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.
Renovations to the MBI’s ground floor provide investigators access to the most up-to-date state-of-the-art facilities.
In a new study published in the Journal of Experimental Medicine, a team led by Cara Croft, Ph.D., has demonstrated a novel method using viruses and mouse brain slice cultures to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. “We’ve been able to set up…
